ASX:IMR

Imricor Medical Systems Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
Volume27,486 shs
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A

Receive IMR News and Ratings via Email

Sign-up to receive the latest news and ratings for Imricor Medical Systems and its competitors with MarketBeat's FREE daily newsletter.


About Imricor Medical Systems

Imricor Medical Systems, Inc., a medical device company, designs, manufactures, sells, and distributes magnetic resonance imaging (MRI) compatible products for cardiac catheter ablation procedures in the United States. The company's principal products include the Advantage-MR EP Recorder/Stimulator system, an electrophysiology amplifier and recording system with integrated cardiac stimulator; Vision-MR Ablation Catheter, which is used as an indication for treating type I atrial flutter; and Vision-MR Dispersive Electrode that is used to minimize eddy currents induced on the conductive pads during MR scanning. The company also performs contract research, as well as licenses its intellectual property for use in implantable devices. Imricor Medical Systems, Inc. was incorporated in 2006 and is headquartered in Burnsville, Minnesota.

Headlines

See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous


MarketRank

Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Imricor Medical Systems (ASX:IMR) Frequently Asked Questions

What stocks does MarketBeat like better than Imricor Medical Systems?

Wall Street analysts have given Imricor Medical Systems a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Imricor Medical Systems wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Imricor Medical Systems' key executives?

Imricor Medical Systems' management team includes the following people:
  • Mr. Steve Wedan, CEO, Pres & Exec. Chairman (Age 52, Pay $565k)
  • Ms. Lori Milbrandt, CFO & VP of Fin.
  • Mr. Gregg Stenzel, Chief Operating Officer
  • Mr. Greg Englehardt, Exec. Director of Sales
  • Mr. Nick Twohy, Exec. Director of Marketing
  • Mr. Kobe Lizheng, Company Sec. & Local Agent

Who are some of Imricor Medical Systems' key competitors?

What other stocks do shareholders of Imricor Medical Systems own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Imricor Medical Systems investors own include Gold Standard Ventures (GSV) and Nuwellis (CHFS).

What is Imricor Medical Systems' stock symbol?

Imricor Medical Systems trades on the ASX under the ticker symbol "IMR."

How much money does Imricor Medical Systems make?

Imricor Medical Systems has a market capitalization of $0.00 and generates $702,161.00 in revenue each year.

What is Imricor Medical Systems' official website?

The official website for Imricor Medical Systems is www.imricor.com.

How can I contact Imricor Medical Systems?

The company can be reached via phone at 952-818-8400.


This page was last updated on 8/2/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.